chrX-154460278-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_017514.5(PLXNA3):c.95C>T(p.Thr32Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000522 in 1,207,433 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 22 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017514.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLXNA3 | NM_017514.5 | c.95C>T | p.Thr32Met | missense_variant | 2/33 | ENST00000369682.4 | |
PLXNA3 | XM_047442247.1 | c.95C>T | p.Thr32Met | missense_variant | 2/22 | ||
PLXNA3 | XR_007068193.1 | n.270C>T | non_coding_transcript_exon_variant | 2/32 | |||
PLXNA3 | XR_430556.4 | n.270C>T | non_coding_transcript_exon_variant | 2/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLXNA3 | ENST00000369682.4 | c.95C>T | p.Thr32Met | missense_variant | 2/33 | 1 | NM_017514.5 | P1 | |
PLXNA3 | ENST00000495040.1 | n.146-821C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000534 AC: 6AN: 112297Hom.: 0 Cov.: 25 AF XY: 0.0000290 AC XY: 1AN XY: 34463
GnomAD3 exomes AF: 0.0000664 AC: 12AN: 180657Hom.: 0 AF XY: 0.0000905 AC XY: 6AN XY: 66299
GnomAD4 exome AF: 0.0000521 AC: 57AN: 1095083Hom.: 0 Cov.: 31 AF XY: 0.0000582 AC XY: 21AN XY: 360963
GnomAD4 genome AF: 0.0000534 AC: 6AN: 112350Hom.: 0 Cov.: 25 AF XY: 0.0000290 AC XY: 1AN XY: 34526
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.95C>T (p.T32M) alteration is located in exon 2 (coding exon 1) of the PLXNA3 gene. This alteration results from a C to T substitution at nucleotide position 95, causing the threonine (T) at amino acid position 32 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
PLXNA3-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 08, 2024 | The PLXNA3 c.95C>T variant is predicted to result in the amino acid substitution p.Thr32Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.047% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at